CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-01 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-04-07 | WIERENGA WENDELL Director | Grant or award | +10,593 | 15,471 | ||
| 2022-04-07 | FISHER MARY Director | Grant or award | +5,031 | 5,031 | ||
| 2022-04-07 | Scott Kathleen D. Director | Grant or award | +5,826 | 5,826 | ||
| 2022-04-07 | Sandler Andrew Seth Director | Grant or award | +5,190 | 5,190 | ||
| 2022-04-07 | Bradrick Brittany Director | Grant or award | +5,031 | 5,031 | ||
| 2022-04-07 | HALE DAVID F Director | Grant or award | +15,466 | 19,124 | ||
| 2022-01-12 | Bradrick Brittany Director | Grant or award · Stock Option (right to Buy) | +10,000 | 10,000 | ||
| 2022-01-03 | Sandler Andrew Seth Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-01-03 | Nardo Christopher J. Senior VP, Development | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-01-03 | Van Hoose Kyri K. SVP, Chief Financial Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-01-03 | HALE DAVID F Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-01-03 | WIERENGA WENDELL Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-01-03 | Scott Kathleen D. Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-01-03 | Mento Steven J Director | Grant or award · Stock Option (right to Buy) | +5,000 | 5,000 | ||
| 2022-01-03 | FISHER MARY Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-01-03 | Bedoya-Toro Munera Maria E Senior Vice President | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-01-03 | PROEHL GERALD T President, CEO and Chairman | Grant or award · Stock Option (right to buy) | +197,610 | 197,610 | ||
| 2022-01-03 | PROEHL GERALD T President, CEO and Chairman | Grant or award · Stock Option (right to buy) | +4,517 | 4,517 | ||
| 2022-01-03 | PROEHL GERALD T President, CEO and Chairman | Grant or award · Stock Option (right to buy) | +42,141 | 42,141 |
Page 5 of 9 · 172 trades